Tag Archives: FDA

Finding A Clinical Trial

What’s better (and more difficult) than finding a Vaporeon in Pokemon Go?

Finding a clinical trial for ALS within reasonable distance!

Our friends at TrialReach have a new widget which does all the searching work for you! Simply plug in a few bits of information such as condition (ie Amyotrophic Lateral Sclerosis}, age, gender, and ZIP code, and you will be presented with the trials within the distance you specify. You can click each to find out more details, and/or you can further refine your search criteria.

For the benefit of the entire global ALS Community, we have installed the widget on this website. Please check it out!

For many conditions, especially ALS, a clinical trial represents the only shot at survival. Patients should quickly enroll so clinical trials can be completed as swiftly as possible and the treatment can be advanced to market or science can move on to the next candidate.

As all PALS know, time is our most precious commodity. Check out the new page, plug your information into the widget, and (if you qualify) enroll in a clinical trial today! Not only could it save your life, your timely action could save the lives of countless others.

Mission: Petition

Recently there has been excitement in the global ALS Community surrounding a press release from a company called Genervon. Following that, a petition to the FDA was launched in support of Genervon’s intention to seek Accelerated Approval. While the data presented so far isn’t quite conclusive for immediate full approval, it is nonetheless intriguing.

Clearly the current status quo in research and development of ALS therapies is insufficient. That’s why SciOpen Research Group was founded. SRG supports the grassroots efforts of patients to change that paradigm. The Accelerated Approval Program requires data capture just like a regular trial except that it would be open to all PALS. Set up with a strict dosing and data collection protocol, this is a perfect compromise between patients wishing to try experimental drugs and the need for scientific information.

Therefore, SciOpen Research Group supports this petition and urges readers to sign and widely share it.